
NGEN Market Capitalization Overview
Market Cap: $475.18M as of Jan 8, 2026
$475.18M
$147.70M (45.10%)past month
As of Jan 8, 2026, NGEN has a market capitalization of $475.18M. Over the past 30 days, its market cap has increased by 44.29%, while in the last 12 months, it has increased by 8.28%.
Market capitalization represents the total value of NervGen Pharma Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NGEN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NGEN helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of NervGen Pharma Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NGEN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NGEN helps investors assess the company's size and compare it with competitors for better investment decisions.
NGEN Market Cap & Key Trends
See NervGen Pharma Corp’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in NGEN
Order type
Buy in
Order amount
Est. shares
0 shares
NGEN Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $324.35M | +80.10% |
| Nov 3, 2025 | $180.10M | -2.69% |
| Oct 1, 2025 | $185.08M | -2.76% |
| Sep 2, 2025 | $190.34M | +6.16% |
| Aug 1, 2025 | $179.30M | -1.13% |
| Jul 1, 2025 | $181.35M | -2.98% |
| Jun 2, 2025 | $186.93M | +16.63% |
| May 1, 2025 | $160.27M | +8.14% |
| Apr 1, 2025 | $148.21M | +9.15% |
| Mar 3, 2025 | $135.78M | -4.30% |
| Feb 3, 2025 | $141.88M | -13.02% |
| Jan 2, 2025 | $163.12M | +12.62% |
NGEN End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $475.18M | +8.28% |
| 2025 | $438.85M | +186.32% |
| 2024 | $153.28M | +26.26% |
| 2023 | $121.40M | +73.85% |
| 2022 | $69.83M | +19.55% |
| 2021 | $58.42M | — |
FAQs About NervGen Pharma Corp (NGEN) Market Cap
As of Jan 8, 2026, the market capitalization of NGEN is $475.18M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, NervGen Pharma Corp’s market capitalization has increased by 45.10%, changing from $327.48M to $475.18M as of Jan 8, 2026.
In the last 3 months, NervGen Pharma Corp’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, NervGen Pharma Corp’s market capitalization increased from $153.28M in January to $438.85M in December, reflecting a 186.32% change.
In the past five years, NGEN has had a compound annual growth rate (CAGR) of 49.68% in market capitalization. This means its market cap has grown at an average rate of 49.68% per year.